Be a part of 4^th European Pathology Congress

This track highlights advancements in digital pathology and artificial intelligence that are transforming diagnostic workflows. Sessions will cover whole-slide imaging, AI-based image analysis, machine learning algorithms, and validation of digital tools. Discussions will emphasize accuracy, reproducibility, regulatory challenges, and clinical implementation, showcasing how digital innovation improves efficiency, diagnostic consistency, and patient outcomes.

• Track 2-1: AI-Assisted Image Analysis
• Track 2-2: Whole-Slide Imaging & Automation
• Track 2-3: Digital Workflow Integration

This track addresses diagnostic, prognostic, and predictive aspects of tumor pathology across solid malignancies. Emphasis is placed on tumor classification, grading, staging, molecular alterations, and pathology-guided therapeutic strategies. Abstracts highlighting clinicopathologic correlations, emerging biomarkers, and personalized oncology approaches are encouraged to demonstrate pathology’s role in modern cancer care.

• Track 3-1: Solid Tumor Classification
• Track 3-2: Prognostic & Predictive Biomarkers
• Track 3-3: Pathology-Guided Oncology

This track focuses on benign and malignant breast diseases with an emphasis on translational research. Topics include histomorphology, molecular subtyping, predictive biomarkers, and therapy response assessment. Submissions addressing integration of pathology findings into clinical management, personalized treatment strategies, and emerging diagnostic technologies are particularly encouraged.

• Track 4-1: Molecular Subtyping of Breast Cancer
• Track 4-2: Predictive & Prognostic Markers
• Track 4-3: Therapy Response Evaluation

This track covers pathological aspects of gastrointestinal and liver diseases, including inflammatory, metabolic, infectious, and neoplastic conditions. Abstracts may address morphologic patterns, molecular alterations, and clinicopathologic correlations. Emphasis is placed on improving diagnostic accuracy, early detection of malignancies, and understanding disease progression.

• Track 5-1: GI Tract Neoplasms
• Track 5-2: Liver & Biliary Disorders
• Track 5-3: Inflammatory & Metabolic Diseases

This track focuses on diseases of the blood, bone marrow, and lymphoid tissues. Topics include leukemias, lymphomas, myelodysplastic syndromes, and plasma cell disorders. Submissions highlighting flow cytometry, cytogenetics, molecular diagnostics, and integrated reporting approaches are encouraged to reflect advancements in hematologic diagnosis and classification.

• Track 6-1: Leukemia & Lymphoma Diagnostics
• Track 6-2: Flow Cytometry & Molecular Tools
• Track 6-3: Bone Marrow Pathology

This track emphasizes kidney and urinary tract pathology, including glomerular, tubular, interstitial, and transplant-related diseases. Abstracts may explore morphologic patterns, immunopathology, molecular insights, and clinicopathologic correlations. Advances in classification systems and emerging diagnostic technologies are particularly welcomed.

• Track 7-1: Glomerular & Tubulointerstitial Diseases
• Track 7-2: Transplant & Rejection Pathology
• Track 7-3: Urologic Neoplasms

This track focuses on neoplastic and non-neoplastic disorders of the head and neck region. Topics include mucosal lesions, salivary gland pathology, HPV-associated tumors, and diagnostic challenges. Abstracts emphasizing morphologic, immunohistochemical, and molecular approaches to accurate diagnosis are encouraged.

• Track 8-1: HPV-Related Head & Neck Tumors
• Track 8-2: Salivary Gland Pathology
• Track 8-3: Salivary Gland Pathology

This track highlights advances in cytologic diagnosis and minimally invasive techniques. Topics include exfoliative and aspiration cytology, molecular cytopathology, and liquid biopsy applications. Emphasis is placed on early cancer detection, biomarker analysis, and integration of cytology with histopathology and molecular findings.

• Track 9-1: Diagnostic Cytology Techniques
• Track 9-2: Liquid Biopsy & Circulating Biomarkers
• Track 9-3: Molecular Cytopathology

This track explores immune-mediated diseases and the role of the immune system in cancer progression and therapy. Topics include immunohistochemistry, immune profiling, inflammatory disorders, and biomarkers predicting immunotherapy response. Abstracts demonstrating clinical relevance and translational impact are encouraged.

• Track 10-1: Immune Profiling & Biomarkers
• Track 10-2: Inflammatory & Autoimmune Diseases
• Track 10-3: Immunotherapy Response Assessment

This track addresses laboratory medicine and its role in disease diagnosis and monitoring. Topics include clinical chemistry, hematology, quality assurance, and laboratory management. Emphasis is placed on clinical correlation, standardization, and innovations that enhance diagnostic accuracy and patient safety

• Track 11-1: Clinical Chemistry & Biomarkers
• Track 11-2: Laboratory Quality & Accreditation
• Track 11-3: Diagnostic Correlation & Monitoring

This track focuses on morphologic evaluation of tissues using traditional and advanced histopathologic techniques. Topics include routine diagnostics, special stains, immunohistochemistry, and digital histology. Case-based submissions highlighting diagnostic challenges and best practices are encouraged.

• Track 12-1: Diagnostic Histomorphology
• Track 12-2: Advanced Staining & IHC
• Track 12-3: Case-Based Surgical Pathology

This track covers medicolegal pathology, forensic investigations, and autopsy-based studies. Topics include cause-of-death determination, molecular forensics, and postmortem diagnostics. Abstracts emphasizing technological advances and interdisciplinary collaboration are welcomed.

• Track 13-1: Medicolegal Investigations
• Track 13-2: Molecular & Digital Forensics
• Track 13-3: Autopsy Pathology

This track highlights experimental models and translational research that bridge basic science and clinical practice. Topics include disease modeling, organoids, animal studies, and biomarker validation. Emphasis is placed on translating laboratory discoveries into diagnostic and therapeutic applications.

• Track 14-1: Disease Models & Organoids
• Track 14-2: Translational Biomarker Research
• Track 14-3: Bench-to-Bedside Applications